NCT05684718View on ClinicalTrials.gov

To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

October 31, 2023

Conditions
Bacterial Infections
Interventions
DRUG

BV100 (300 mg)

Intravenous solution

DRUG

Itraconazole 200 mg

Oral solution

Trial Locations (1)

H-2143

CRU Hungary Kft., Early Phase Unit, Kistarcsa

Sponsors

Lead Sponsor

BioVersys AG
All Listed Sponsors
collaborator

Clinical Research Units Hungary

OTHER

lead

BioVersys AG

INDUSTRY